Alex Bahar-Fuchs

A 12-week multidomain intervention versus active control to reduce risk of Alzheimer’s disease: study protocol for a randomized controlled trial

George W Rebok, Kaarin J Anstey, Nicolas Cherbuin, 2013, Trials.

Olfactory deficits and amyloid-β burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET study.

Greg Savage, Christopher Rowe, Colin L Masters, 2011, Journal of Alzheimer's disease : JAD.

Virtual reality-based cognitive-motor training for middle-aged adults at high Alzheimer's disease risk: A randomized controlled trial

Amihai Gottlieb, Meir Plotnik, Gabi Zeilig, 2018, Alzheimer's & dementia.

Prediction of amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests.

Christopher C Rowe, Victor Villemagne, Michael Woodward, 2012, Journal of Alzheimer's disease : JAD.

DETECTION OF PRODROMAL ALZHEIMER'S DISEASE WITH 18F-FLORBETABEN Aβ IMAGING: A PROSPECTIVE OUTCOME STUDY

John Seibyl, Victor L. Villemagne, Beate Rohde, 2014, Alzheimer's & Dementia.

Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study

John Seibyl, Ana M Catafau, Christopher C Rowe, 2014, Journal of Neurology, Neurosurgery & Psychiatry.

Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia.

Bob Woods, Linda Clare, L. Clare, 2013, The Cochrane database of systematic reviews.

Cognitive training and cognitive rehabilitation for persons with mild to moderate dementia of the Alzheimer's or vascular type: a review

Bob Woods, Linda Clare, L. Clare, 2013, Alzheimer's Research & Therapy.